Zevra Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ZVRA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1180 Celebration Boulevard, Suite 103, Celebration, FL

Insiders trading volume in the past year

Zevra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samuel J. Braun 10%+ Owner $15.6M May 13, 2021
Neil F. McFarlane President and CEO, Director $3.47M Jan 31, 2024
Rahsaan Thompson Chief Legal & Compliance, Secretary $992K Jun 21, 2024
Travis C. Mickle President & CEO, Director $852K May 25, 2022
R. LaDuane Clifton CFO & Treasurer $770K +$13.5K +1.79% Jul 17, 2024
Joshua Schafer CCO & EVP, Bus. Development $543K Jan 31, 2024
Sven Guenther Chief Scientific Officer $392K Jan 31, 2024
Christal M. M. Mickle Chief Development Officer $382K Jan 31, 2024
Timothy J. Sangiovanni SVP, Corporate Controller $196K Jan 31, 2024
John B. Bode Director $176K +$58.7K +50% Jul 12, 2024
Richard W. Pascoe Chief Executive Officer, Director $149K Mar 9, 2023
Thomas Anderson Director $136K +$68.1K +100% Jul 16, 2024
David S. Tierney Director $53.7K Mar 9, 2023
Corey M. Watton Director $4.96K May 13, 2024
Christopher Posner Director Nov 28, 2022
Alvin Shih Director May 13, 2024
Matthew R. Plooster Director Apr 25, 2023
Tamara A. Favorito Director May 13, 2024
Wendy L. Dixon Director May 13, 2024
Douglas W. Calder Director May 13, 2024
Joseph Saluri Director Apr 25, 2023

Recent Insider Transactions by Companies or Individuals for Zevra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.